DK1890684T3 - Behandling af søvn/vågenhedsforstyrrelser - Google Patents

Behandling af søvn/vågenhedsforstyrrelser

Info

Publication number
DK1890684T3
DK1890684T3 DK06772647.1T DK06772647T DK1890684T3 DK 1890684 T3 DK1890684 T3 DK 1890684T3 DK 06772647 T DK06772647 T DK 06772647T DK 1890684 T3 DK1890684 T3 DK 1890684T3
Authority
DK
Denmark
Prior art keywords
sleep
treatment
wakefulness disorders
wakefulness
disorders
Prior art date
Application number
DK06772647.1T
Other languages
English (en)
Inventor
Joseph Palumbo
Jonathan Sporn
Abdallah Ahnaou
Wilhelmus H I M Drinkenburg
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37085728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1890684(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Application granted granted Critical
Publication of DK1890684T3 publication Critical patent/DK1890684T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06772647.1T 2005-06-08 2006-06-07 Behandling af søvn/vågenhedsforstyrrelser DK1890684T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68863805P 2005-06-08 2005-06-08
PCT/US2006/022407 WO2006133393A1 (en) 2005-06-08 2006-06-07 Treatment of sleep-wake disorders

Publications (1)

Publication Number Publication Date
DK1890684T3 true DK1890684T3 (da) 2013-10-14

Family

ID=37085728

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06772647.1T DK1890684T3 (da) 2005-06-08 2006-06-07 Behandling af søvn/vågenhedsforstyrrelser

Country Status (16)

Country Link
US (6) US8440715B2 (da)
EP (1) EP1890684B1 (da)
JP (1) JP5024635B2 (da)
KR (1) KR101335941B1 (da)
CN (1) CN101217949B (da)
AU (1) AU2006254899B2 (da)
BR (1) BRPI0613697A2 (da)
CA (1) CA2611713C (da)
DK (1) DK1890684T3 (da)
ES (1) ES2435403T3 (da)
FR (1) FR20C1014I2 (da)
NL (1) NL301037I2 (da)
PL (1) PL1890684T3 (da)
RU (1) RU2417077C2 (da)
TW (2) TW201328689A (da)
WO (1) WO2006133393A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1890684B1 (en) 2005-06-08 2013-08-14 SK Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
KR101335942B1 (ko) * 2005-06-22 2013-12-04 에스케이바이오팜 주식회사 성기능 장애의 치료
US8741950B2 (en) * 2009-06-22 2014-06-03 Sk Biopharmaceuticals Co., Ltd. Methods for treating or preventing fatigue
US8232315B2 (en) * 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
JP5836280B2 (ja) 2009-11-06 2015-12-24 エスケー バイオファーマスティカルズ カンパニー リミテッド 注意欠陥/多動性障害(adhd)の治療方法
CA2779442A1 (en) * 2009-11-06 2011-05-12 Sk Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
US8623913B2 (en) * 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) * 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
SG11201507121RA (en) 2013-03-13 2015-10-29 Aerial Biopharma Llc Treatment of cataplexy
DK3021838T3 (da) * 2013-07-18 2020-08-24 Jazz Pharmaceuticals Ireland Ltd Behandling af fedme
US10888542B2 (en) 2014-02-28 2021-01-12 Sk Biopharmaceuticals Co., Ltd. Aminocarbonylcarbamate compounds
TWI698415B (zh) 2014-02-28 2020-07-11 南韓商愛思開生物製藥股份有限公司 胺基羰基胺基甲酸酯化合物
WO2016061488A1 (en) * 2014-10-17 2016-04-21 Concert Pharmaceuticals, Inc. Amine reuptake inhibitors
JP6466792B2 (ja) * 2015-07-03 2019-02-06 エスケー バイオファーマスティカルズ カンパニー リミテッド 注意欠陥/多動性障害(adhd)の治療方法
TWI637765B (zh) * 2016-05-10 2018-10-11 台灣共振波研發股份有限公司 Soothing device for attention deficit hyperactivity disorder
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
FI3509582T3 (fi) 2016-09-06 2024-02-08 Axsome Malta Ltd (r)-2-amino-3-fenyylipropyylikarbamaatin solvaattimuoto
SG11201903076QA (en) 2016-10-06 2019-05-30 Jazz Pharmaceuticals International Iii Ltd Carbamoyl phenylalaninol compounds and uses therof
CN111201014A (zh) 2017-06-02 2020-05-26 爱尔兰贾兹制药有限公司 治疗过度嗜睡的方法和组合物
CN111094238B (zh) 2017-07-31 2023-06-09 杰资制药爱尔兰有限公司 氨基甲酰基苯丙氨醇类似物及其用途
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function
US11033214B1 (en) * 2020-05-19 2021-06-15 United Arab Emirates University Wearable eye tracking system
KR102390194B1 (ko) 2020-08-03 2022-04-25 셀라이온바이오메드 주식회사 페닐알킬 카바메이트 화합물을 포함하는 Kca3.1채널 매개질환 치료용 조성물

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2939660A1 (de) * 1979-09-29 1981-04-16 Basf Ag, 6700 Ludwigshafen Neue carbamate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
ZA943862B (en) 1993-06-10 1995-12-04 Lilly Co Eli Method of preventing emesis and treating sexual dysfunction using tetrahydrobenz[cd] indole-6-carboxamides
KR100197892B1 (ko) 1994-09-09 1999-06-15 남창우 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법
KR0173862B1 (ko) * 1995-02-11 1999-04-01 조규향 O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
US5756817C1 (en) * 1995-02-11 2001-04-17 Sk Corp O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same
KR0173863B1 (ko) 1995-04-10 1999-04-01 조규향 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
PT873308E (pt) * 1996-10-10 2002-06-28 Sk Corp Compostos de o-carbamoil-fenilalaninol seus sais farmaceuticamente uteis e processo para a preparacao dos mesmos
WO1998017636A1 (en) 1996-10-22 1998-04-30 Ortho Pharmaceutical Corporation Phenylalaninol derivatives for the treatment of central nervous system disorders
CN1250215C (zh) * 2001-02-27 2006-04-12 奥索-麦克尼尔药品公司 用于预防或治疗双相性精神障碍的氨基甲酸酯化合物
DK1399144T3 (da) * 2001-02-27 2006-07-24 Ortho Mcneil Pharm Inc Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
US6589985B2 (en) * 2001-02-27 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating movement disorders
US20050080268A1 (en) 2003-10-08 2005-04-14 Yong-Moon Choi Process of preparing O-carbamoyl compounds in the presence of active amine group
US20050203130A1 (en) * 2003-12-02 2005-09-15 Erik Buntinx Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
AU2005302589B2 (en) 2004-10-28 2010-09-16 Sk Biopharmaceuticals Co., Ltd. Adjunctive therapy for depression
EP1890684B1 (en) 2005-06-08 2013-08-14 SK Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
KR101335942B1 (ko) 2005-06-22 2013-12-04 에스케이바이오팜 주식회사 성기능 장애의 치료
WO2007018496A1 (en) 2005-07-26 2007-02-15 Janssen Pharmaceutica, N.V. Methods for treating substance-related disorders
EP2079449A2 (en) 2006-10-13 2009-07-22 Janssen Pharmaceutica, N.V. Phenylalkylamino carbamate compositions
US8741950B2 (en) 2009-06-22 2014-06-03 Sk Biopharmaceuticals Co., Ltd. Methods for treating or preventing fatigue
US8232315B2 (en) 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
CA2779442A1 (en) 2009-11-06 2011-05-12 Sk Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
JP5836280B2 (ja) 2009-11-06 2015-12-24 エスケー バイオファーマスティカルズ カンパニー リミテッド 注意欠陥/多動性障害(adhd)の治療方法
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
KR102005483B1 (ko) 2012-10-19 2019-07-31 삼성디스플레이 주식회사 박막 트랜지스터 기판 및 그의 수리 방법
SG11201507121RA (en) * 2013-03-13 2015-10-29 Aerial Biopharma Llc Treatment of cataplexy

Also Published As

Publication number Publication date
FR20C1014I2 (fr) 2021-04-23
CA2611713C (en) 2013-10-01
US20170158622A1 (en) 2017-06-08
KR101335941B1 (ko) 2013-12-04
US20210078943A1 (en) 2021-03-18
US20190367448A1 (en) 2019-12-05
RU2417077C2 (ru) 2011-04-27
EP1890684A1 (en) 2008-02-27
PL1890684T3 (pl) 2014-05-30
US9604917B2 (en) 2017-03-28
AU2006254899A1 (en) 2006-12-14
JP5024635B2 (ja) 2012-09-12
US20130137764A1 (en) 2013-05-30
CN101217949A (zh) 2008-07-09
BRPI0613697A2 (pt) 2011-01-25
US8440715B2 (en) 2013-05-14
US11753368B2 (en) 2023-09-12
RU2008100019A (ru) 2009-07-20
US20090312416A1 (en) 2009-12-17
AU2006254899B2 (en) 2011-11-24
NL301037I2 (nl) 2020-05-12
FR20C1014I1 (da) 2020-06-12
TWI419681B (zh) 2013-12-21
CN101217949B (zh) 2012-10-17
EP1890684B1 (en) 2013-08-14
NL301037I1 (da) 2020-04-01
US20140350098A1 (en) 2014-11-27
ES2435403T3 (es) 2013-12-19
TW201328689A (zh) 2013-07-16
KR20080035565A (ko) 2008-04-23
US10351517B2 (en) 2019-07-16
TW200716084A (en) 2007-05-01
JP2008545795A (ja) 2008-12-18
CA2611713A1 (en) 2006-12-14
US8877806B2 (en) 2014-11-04
WO2006133393A1 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
DK1890684T3 (da) Behandling af søvn/vågenhedsforstyrrelser
DK1962869T3 (da) Behandling af luftvejssygdomme
DK1720866T3 (da) Fremgangsmåde
DK1938528T3 (da) Provision af qos-behandling baseret på flere anmodninger
DK1937633T3 (da) Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme
DK2056807T3 (da) Behandling af inflammatoriske sygdomme
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
BRPI0812361A2 (pt) Derivados de pirazol heteroaril-substituídos úteis parao tratamento de distúrbios e doenças hiperproliferativos associados à angiogênese
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
DK2222272T3 (da) Behandling af luftvejssygdom
NO20070251A (no) Brønnbehandling
DK1863899T3 (da) Hudbehandlingspræparater
NO20070297A (no) Brønnbehandling
DK1940409T3 (da) Nye lægemiddelkombinationer til behandling af åndedrætssygdomme
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
DK1744781T3 (da) Behandling af infektionssygdomme
DK1841433T3 (da) Præparat til behandling af lidelser i centralnervesystemet
DK1907374T3 (da) Til behandling af gastrointestinale sygdomme anvendelige benzylpiperazin-derivater
DK1491212T3 (da) Middel til behandling af søvnforstyrrelser
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2056858T3 (da) Behandling af lungesygdomstilstande
BRPI0818121A2 (pt) diespiro 1,2,4-trioxolano e seus métodos de fabricação e utilização
DK2054050T3 (da) Behandling af brusksygdomme med FGF-18